Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Forbion Ventures

Tracked across 2 events · 12 articles · First seen Jul 08, 2026 · Last active Aug 19, 2026

Sentiment
25
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 50
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Forbion Ventures participated in the private placement and will have board representation in the combined company.
Aug 17, 2026 · 6 articles
1 0
Business
Impact: Patrick Vink is a senior advisor to Forbion Ventures.
Jul 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Forbion Ventures live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.